CPT1A and prostate carcinoma: It was recently demonstrated that in prostate cancer cell models, overexpression of Cpt1a is associated with a significant increase in intracellular lipase activity (40), a step that liberates fatty acids from triglyceride stores, which can then be used for β-oxidation (41).